Literatur
-
1
Chen R Z, Pettersson U, Beard C. et al. .
DNA hypomethylation leads to elevated
mutation rates.
Nature.
1998;
395(6697)
89-93
-
2
Bender C M, Pao M M, Jones P A.
Inhibition of DNA methylation by 5-aza-2" deoxycytidine suppresses
the growth of human tumor cell lines.
Cancer Res..
1998;
58(1)
95-101
-
3
Esteller M.
Epigenetic
lesions causing genetic lesions in human cancer: promoter hypermethylation
of DNA repair genes.
Eur J Cancer.
2000;
36(18)
2294-2300
-
4
Esteller M, Corn P G, Baylin S B, Herman J G.
A gene
hypermethylation profile of human cancer.
Cancer Res.
2001;
61(8)
3225-3229
-
5
Esteller M, Sanchez-Cespedes M, Rosell R. et al. .
Detection
of aberrant promoter hypermethylation of tumor suppressor genes
in serum DNA from non-small cell lung cancer patients.
Cancer
Res.
1999;
59(1)
67-70
-
6
Laird P W, Jaenisch R.
The role of DNA methylation
in cancer genetic and epigenetics.
Annu Rev Genet.
1996;
30
441-464
-
7
Robertson K D, Jones P A.
DNA methylation: past,
present and future directions.
Carcinogenesis.
2000;
21(3)
461-467
-
8
Silverman L R, Demakos E P, Peterson B L. et al .
Randomized controlled trial
of azacitidine in patients with the myelodysplastic syndrome: a
study of the cancer and leukemia group B.
J Clin Oncol.
2002;
20(10)
2429-2440
-
9
Toyota M, Ahuja N, Ohe-Toyota M. et al. .
CpG island
methylator phenotype in colorectal cancer.
Proc Natl Acad
Sci USA.
1999;
96(15)
8681-8686
-
10
Usadel H, Brabender J, Danenberg K D. et al .
Quantitative adenomatous
polyposis coli promoter methylation analysis in tumor tissue, serum,
and plasma DNA of patients with lung cancer.
Cancer Res.
2002;
62(2)
371-375
-
11
Zou H Z, Yu B M, Wang Z. et al .
Detection of aberrant p16 methylation in
the serum of colorectal cancer patients.
Clin Cancer Res.
2002;
8(1)
188-191
Dr. Christian Arnold
Medizinische Universitätsklinik Freiburg,
Abteilung Innere Medizin II
Hugstetter Str. 55
79106 Freiburg
